Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.32−0.06 (-2.52%)
Close on Nov 17, 2026Market cap $137.10MP/E –Yield –
Protara Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2014 it was -257.1%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | -257.1% | – |
See a number that looks wrong?